{{Rsnum
|rsid=2061332
|Gene=LOC100379224
|Chromosome=19
|position=44109508
|Orientation=plus
|GMAF=0.4118
|Gene_s=CEACAMP2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 4.4 | 29.2 | 66.4
| HCB | 21.2 | 51.8 | 27.0
| JPT | 21.2 | 48.7 | 30.1
| YRI | 53.1 | 38.8 | 8.2
| ASW | 42.1 | 45.6 | 12.3
| CHB | 21.2 | 51.8 | 27.0
| CHD | 14.7 | 58.7 | 26.6
| GIH | 8.9 | 35.6 | 55.4
| LWK | 45.5 | 44.5 | 10.0
| MEX | 27.6 | 41.4 | 31.0
| MKK | 40.4 | 46.2 | 13.5
| TSI | 5.9 | 25.5 | 68.6
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs2061332
|Name_s=
|Gene_s=ZNF225, ZNF224
|Feature=
|Evidence=PubMed ID:19118814
|Annotation=This variant is significantly associated with late-onset Alzheimer disease (LOAD) in a GWAS study with 492 LOAD cases and 498 cognitive controls using Illumina's HumanHap550 beadchip.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363837
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2061332
|overall_frequency_n=73
|overall_frequency_d=126
|overall_frequency=0.579365
|n_genomes=40
|n_genomes_annotated=0
|n_haplomes=59
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}